Seroba.

Seroba. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Investing in life sciences. Investing in life. Seroba is a European life sciences venture capital firm based in Dublin, Paris and Milan, investing its fourth Fund. We focus on value creation through backing cutting-edge biotech and medtech innovation that will transform the treatment of unmet medical needs. Our team has deep industry and operational experience and an extensive global network. We like to work with entrepreneurs who share our passion for success and for investors who share the same goal of improving human health while driving financial returns.
Looking for a particular Seroba. employee's phone or email?

Seroba. Questions

News

Seroba Announces Above Target Final Close of its Fund IV at €123M ($134M) - Business Wire

Seroba Announces Above Target Final Close of its Fund IV at €123M ($134M) Business Wire

Shorla Pharma Closes $8.3M Series A Funding Round - PR Newswire

Shorla Pharma Closes $8.3M Series A Funding Round PR Newswire

Irish life sciences VC firm Seroba closes its Fund IV at €123M; will target up to 12 investments - Silicon Canals

Irish life sciences VC firm Seroba closes its Fund IV at €123M; will target up to 12 investments Silicon Canals

Neurovascular Company Perfuze Raises €22.5m ($25m) Series A for New Stroke Treatment - BioSpace

Neurovascular Company Perfuze Raises €22.5m ($25m) Series A for New Stroke Treatment BioSpace

Seroba and Kurma Partners announce completion of total series B financing round of EUR 65.8Mln - World Business Outlook

Seroba and Kurma Partners announce completion of total series B financing round of EUR 65.8Mln World Business Outlook

Dublin's Deciphex rakes in €3.9 million to bring AI to more pathology labs - Tech.eu

Dublin's Deciphex rakes in €3.9 million to bring AI to more pathology labs Tech.eu

Sibylla Biotech raises €23m Series A - European Biotechnology Magazine

Sibylla Biotech raises €23m Series A European Biotechnology Magazine

Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines - GlobeNewswire

Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines GlobeNewswire

Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases - PR Newswire

Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases PR Newswire

Seroba and Kurma Partners Announce Complementary Series B Funding for Vico Therapeutics totaling €65.8 million ($70.7 million) - NTB Kommunikasjon

Seroba and Kurma Partners Announce Complementary Series B Funding for Vico Therapeutics totaling €65.8 million ($70.7 million) NTB Kommunikasjon

Deciphex secures €3.9m in funding - Think Business

Deciphex secures €3.9m in funding Think Business

Ireland bats above its weight in VC terms. Peter Sandys, chairman, Irish Venture Capital Association, Seroba - Irish Tech News

Ireland bats above its weight in VC terms. Peter Sandys, chairman, Irish Venture Capital Association, Seroba Irish Tech News

Shorla Oncology Secures $35M Series B Funding Round to Advance its Oncology Product Portfolio - Business Wire

Shorla Oncology Secures $35M Series B Funding Round to Advance its Oncology Product Portfolio Business Wire

Deciphex secures additional €3.9m funding to boost Digital Pathology & AI services - Irish Tech News - Irish Tech News

Deciphex secures additional €3.9m funding to boost Digital Pathology & AI services - Irish Tech News Irish Tech News

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant